FlowMetric, Inc., Forms New Affiliate Company, FlowMetric Diagnostics Inc. to Develop Advanced Diagnostics from Flow Cytometry Platform

DOYLESTOWN, Pa.--FlowMetric, Inc., a leader in flow cytometry and cell sorting services, announced today the formation of its new affiliate company FlowMetric Diagnostics Inc. for the express purpose of developing advanced companion diagnostics from its flow cytometry platform for use in the global health market.

Flow Cytometry currently has broad applications in R&D as well as drug-design. The sensitivity and analytical capabilities of the modern Flow Cytometry systems combined with FlowMetric Diagnostics Inc. proprietary methods will play a central role in its development of novel and innovative diagnostics.

"This new affiliate company," says Ren Capocasale, FlowMetric CEO, "represents the natural progression of the FlowMetric, Inc. business into the clinical marketplace and recognizes the need for additional diagnostics."

FlowMetric Diagnostics leadership will include Amy Williams as President and Julie Bick, Ph.D. as Chief Scientific Officer. Ren Capocasale will operate as Chairman of the Board.

"The development of new companion diagnostics through flow cytometry can help to advance personalized medicine and better meet the needs of physicians, healthcare workers and patients," said Williams.

FlowMetric Diagnostics Inc. plans to establish a state-of-the-art FDA-compliant clinical Flow Cytometry laboratory in which to perform CLIA-certified diagnostic tests from both the company's own assay portfolio, as well as those of partnering diagnostic companies.

About FlowMetric

FlowMetric, Inc., is a niche contract research organization (CRO), focused on providing polychromatic flow cytometry and cell sorting services to bio-pharma and drug discovery companies. FlowMetric is committed to providing independent, unbiased, comprehensive and precise test services as part of the pre-clinical and clinical trial process for its clients. FlowMetric offers integrated, cost-effective, and specialized polychromatic flow cytometry services delivered with an uncompromising commitment to quality. For more information, visit www.flowmetric.comand www.flowmetricdiagnostics.com.

 

Contacts

FlowMetric, Inc.
Rachel Bunting, MS, MBA
267-893-6630
[email protected]
www.flowmetric.com

 

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.